ATE366807T1 - Fehlpaarungsendonukleasen und verwendungsverfahren - Google Patents

Fehlpaarungsendonukleasen und verwendungsverfahren

Info

Publication number
ATE366807T1
ATE366807T1 AT03706015T AT03706015T ATE366807T1 AT E366807 T1 ATE366807 T1 AT E366807T1 AT 03706015 T AT03706015 T AT 03706015T AT 03706015 T AT03706015 T AT 03706015T AT E366807 T1 ATE366807 T1 AT E366807T1
Authority
AT
Austria
Prior art keywords
heteroduplex
complementarity
polynucleotide
mismatches
increased
Prior art date
Application number
AT03706015T
Other languages
English (en)
Inventor
Hal Padgett
Andrew Vaewhongs
Fakhrieh Vojdani
Mark Smith
John Lindbo
Wayne Fitzmaurice
Original Assignee
Large Scale Biology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/098,155 external-priority patent/US20030157495A1/en
Application filed by Large Scale Biology Corp filed Critical Large Scale Biology Corp
Application granted granted Critical
Publication of ATE366807T1 publication Critical patent/ATE366807T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Disintegrating Or Milling (AREA)
AT03706015T 2002-02-01 2003-01-31 Fehlpaarungsendonukleasen und verwendungsverfahren ATE366807T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35372202P 2002-02-01 2002-02-01
US10/098,155 US20030157495A1 (en) 2002-02-01 2002-03-14 Nucleic acid molecules encoding CEL I endonuclease and methods of use thereof
US10/211,079 US7078211B2 (en) 2002-02-01 2002-08-01 Nucleic acid molecules encoding endonucleases and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE366807T1 true ATE366807T1 (de) 2007-08-15

Family

ID=27739010

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03706015T ATE366807T1 (de) 2002-02-01 2003-01-31 Fehlpaarungsendonukleasen und verwendungsverfahren

Country Status (8)

Country Link
US (4) US7078211B2 (de)
EP (1) EP1565557B1 (de)
JP (1) JP4395632B2 (de)
AT (1) ATE366807T1 (de)
AU (1) AU2003207776B2 (de)
CA (1) CA2473187C (de)
DE (1) DE60314902T2 (de)
WO (1) WO2003066809A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110111413A1 (en) * 2001-02-02 2011-05-12 Padgett Hal S Method of optimizing codon usage through dna shuffling
US7838219B2 (en) * 2001-02-02 2010-11-23 Novici Biotech Llc Method of increasing complementarity in a heteroduplex
ATE447019T1 (de) * 2001-02-02 2009-11-15 Large Scale Biology Corp Methode zur erhöhung der komplementarität in einem heteroduplex-polynucleotid
US7078211B2 (en) * 2002-02-01 2006-07-18 Large Scale Biology Corporation Nucleic acid molecules encoding endonucleases and methods of use thereof
EP1574570A1 (de) * 2004-03-12 2005-09-14 Universität Regensburg Verfahren zur Verringerung der Anzahl von fehlgepaarten Nukleotiden in doppelsträngigen Polynukleotiden
ES2292270B1 (es) * 2004-04-14 2009-02-16 Oryzon Genomics, S.A. Procedimiento para detectar selectivamente acidos nucleicos con estructuras atipicas convertibles en muescas.
US20060029612A1 (en) * 2004-04-15 2006-02-09 Large Scale Biology Corporation Prevention and treatment of recurrent respiratory papillomatosis
US7729761B2 (en) * 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
ATE495243T1 (de) * 2004-07-30 2011-01-15 Genoplante Valor Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung
EP1904638A2 (de) * 2005-07-18 2008-04-02 Metabogal Ltd. Mukosale oder enterale verabreichung biologisch aktiver makromoleküle
EP1934335A4 (de) * 2005-09-08 2010-05-05 Large Scale Biology Corp Modifizierte tabak-mosaikvirus-teilchen als gerüste zur anzeige von protein-antigenen für impfstoff-anwendungen
WO2007101028A2 (en) * 2006-02-24 2007-09-07 Transgenomic, Inc. Method to produce enzymatically active recombinant endonucleases
US7888475B2 (en) * 2008-09-15 2011-02-15 Padgett Hal S Interferon alpha and interferon kappa fusion protein
WO2011102802A1 (en) * 2010-02-18 2011-08-25 Agency For Science, Technology And Research Method for reducing mismatches in double-stranded dna molecules
CN103945931B (zh) 2011-09-26 2017-03-22 基因技术股份公司 高效的小体积核酸合成
WO2014153188A2 (en) 2013-03-14 2014-09-25 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
CA3156904A1 (en) * 2012-02-01 2013-08-08 Synthetic Genomics, Inc. Materials and methods for the synthesis of error-minimized nucleic acid molecules
WO2013152220A2 (en) 2012-04-04 2013-10-10 Life Technologies Corporation Tal-effector assembly platform, customized services, kits and assays
US20150119260A1 (en) * 2013-10-18 2015-04-30 National Taiwan University Circulating cancer biomarker and its use
WO2016011174A1 (en) 2014-07-15 2016-01-21 Life Technologies Corporation Compositions and methods for nucleic acid assembly
CA3147259A1 (en) 2014-12-09 2016-06-16 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
EP3320103A1 (de) 2015-07-07 2018-05-16 Thermo Fisher Scientific Geneart GmbH Enzymatische synthese von nukleinsäuresequenzen
EP3359669B1 (de) 2015-10-06 2020-05-13 Pierce Biotechnology, Inc. Vorrichtungen und verfahren zur herstellung von proteinen
EP3405589A1 (de) * 2016-01-22 2018-11-28 Vyome Biosciences Pvt. Ltd. Verfahren zum nachweis und zur behandlung von p. acnes und kit dafür
EP3814494B1 (de) 2018-06-29 2023-11-01 Thermo Fisher Scientific GENEART GmbH Hochdurchsatzanordnung von nukleinsäuremolekülen
GB201905303D0 (en) 2019-04-15 2019-05-29 Thermo Fisher Scient Geneart Gmbh Multiplex assembly of nucleic acid molecules
WO2021178809A1 (en) 2020-03-06 2021-09-10 Life Technologies Corporation High sequence fidelity nucleic acid synthesis and assembly
EP4095254A3 (de) 2021-05-27 2022-12-14 New England Biolabs, Inc. Fragmentierung von dna
EP4638776A1 (de) 2022-12-19 2025-10-29 Thermo Fisher Scientific GENEART GmbH Rückgewinnung von sequenzverifizierten nukleinsäuremolekülen

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US45175A (en) * 1864-11-22 Improved grinding-plate
US17477A (en) * 1857-06-09 allerton
US48268A (en) * 1865-06-20 Improved process for preparing coffee
EP1186660A3 (de) * 1985-03-30 2002-03-20 KAUFFMAN, Stuart A. Verfahren zum Erhalten von DNA, RNA, Peptiden, Polypeptiden oder Proteinen durch ein DNA-Rekombinations-Verfahren
US4994368A (en) * 1987-07-23 1991-02-19 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
US5556750A (en) * 1989-05-12 1996-09-17 Duke University Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems
US5459039A (en) * 1989-05-12 1995-10-17 Duke University Methods for mapping genetic mutations
US5556747A (en) * 1990-07-09 1996-09-17 E. R. Squibb & Sons, Inc. Method for site-directed mutagenesis
US5795747A (en) * 1991-04-16 1998-08-18 Evotec Biosystems Gmbh Process for manufacturing new biopolymers
DE4112440C1 (de) 1991-04-16 1992-10-22 Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De
AU3919293A (en) * 1992-03-27 1993-11-08 University Of Maryland At Baltimore Detection of gene mutations with mismatch repair enzymes
US6165793A (en) * 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
EP0832210B1 (de) 1995-06-07 2004-10-27 Trevigen, Inc. Methode zur detektion von punktmutanten mittels nukleinsäurereperaturenzym und in vitro mutagenese
US6057103A (en) * 1995-07-18 2000-05-02 Diversa Corporation Screening for novel bioactivities
US5922539A (en) * 1995-12-15 1999-07-13 Duke University Methods for use of mismatch repair systems for the detection and removal of mutant sequences that arise during enzymatic amplification
WO1997037011A1 (en) 1996-04-01 1997-10-09 Setratech S.A.R.L. Meiotic recombination in vivo of partially homologous dna sequences
US5869245A (en) * 1996-06-05 1999-02-09 Fox Chase Cancer Center Mismatch endonuclease and its use in identifying mutations in targeted polynucleotide strands
WO1997046701A1 (en) 1996-06-05 1997-12-11 Fox Chase Cancer Center Mismatch endonucleases and uses thereof in identifying mutations in targeted polynucleotide strands
FR2772048B1 (fr) 1997-12-04 2001-12-21 Biomethodes Procede de clonage par digestion multiple, vecteurs pour sa mise en oeuvre et ses applications
DK1036198T3 (da) 1997-12-08 2013-01-02 California Inst Of Techn Fremgangsmåde til fremstilling af polynukleotid- og polypeptidsekvenser
US6846655B1 (en) * 1998-06-29 2005-01-25 Phylos, Inc. Methods for generating highly diverse libraries
FR2789696A1 (fr) 1999-02-12 2000-08-18 Biomethodes Procede de mutagenese d'un fragment d'acide nucleique par clonage et polymerisation-ligation
FR2793807B1 (fr) 1999-05-20 2003-05-16 Biomethodes Methode d'insertion d'un fragment d'acide nucleique dans un vecteur, ses applications et les kits pour sa mise en oeuvre
DE19953854C2 (de) 1999-11-09 2002-01-17 Max Planck Gesellschaft Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften
US6391557B1 (en) * 2000-02-22 2002-05-21 Fox Chase Cancer Center Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof
EP1257671B1 (de) 2000-02-22 2015-01-14 Fox Chase Cancer Center Fehlpaarungsendonuklease kodierendes nukleinsäuremolekül und verfahren zu dessen verwendung
EP1283877A2 (de) * 2000-05-23 2003-02-19 California Institute Of Technology Gen-rekombination und hybridprotein entwicklung
FR2813314B1 (fr) 2000-08-25 2004-05-07 Biomethodes Procede de mutagenese dirigee massive
WO2002024953A1 (en) 2000-09-21 2002-03-28 Merck & Co., Inc. Method for generating recombinant polynucleotides
US6783941B2 (en) * 2000-12-06 2004-08-31 Novozymes A/S Method for producing a polynucleotide library in vitro by mismatch repair of heteroduplexes
ATE447019T1 (de) 2001-02-02 2009-11-15 Large Scale Biology Corp Methode zur erhöhung der komplementarität in einem heteroduplex-polynucleotid
US7078211B2 (en) * 2002-02-01 2006-07-18 Large Scale Biology Corporation Nucleic acid molecules encoding endonucleases and methods of use thereof
DE10248258A1 (de) 2002-10-16 2004-05-06 Biopsytec Analytik Gmbh Mutierte Nukleinsäure einer Cel I-Endonuklease und Verfahren zur Herstellung des rekombinanten vollständigen Cel I-Proteins

Also Published As

Publication number Publication date
EP1565557A2 (de) 2005-08-24
EP1565557A4 (de) 2005-11-30
WO2003066809A3 (en) 2005-06-30
CA2473187C (en) 2012-07-31
US7078211B2 (en) 2006-07-18
US20030148315A1 (en) 2003-08-07
AU2003207776B2 (en) 2008-12-11
DE60314902T2 (de) 2008-04-10
WO2003066809A2 (en) 2003-08-14
US20080145913A1 (en) 2008-06-19
DE60314902D1 (de) 2007-08-23
US7056740B2 (en) 2006-06-06
JP2005529586A (ja) 2005-10-06
JP4395632B2 (ja) 2010-01-13
AU2003207776A1 (en) 2003-09-02
US7273739B2 (en) 2007-09-25
US20030157682A1 (en) 2003-08-21
CA2473187A1 (en) 2003-08-14
EP1565557B1 (de) 2007-07-11
US20060194288A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
ATE366807T1 (de) Fehlpaarungsendonukleasen und verwendungsverfahren
DE60234159D1 (de) Methode zur erhöhung der komplementarität in einem heteroduplex-polynucleotid
WO2006063072A3 (en) Immunomodulatory compositions, combinations and methods
WO2002026727A3 (en) Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai
ATE513911T1 (de) Verfahren und zusammensetzungen für rna- interferenz
EP2239327A3 (de) Verfahren zur In-Vitro-Rekombination
CA2398675A1 (en) Modified low temperature case hardening processes
WO2002098210A3 (en) Chromosome doubling method
NZ521698A (en) Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
GB2409675B (en) Modification of the colour of a single crystal CVD diamond
SG146682A1 (en) Modulation of eif4e expression
WO2004101889A8 (en) Use of hemicellulase composition in mechanical pulp production
DE60107437D1 (de) Behandlung eines substrates aus nichtrostendem stahl
DE602005023892D1 (de) Verbundfasern, die mindestens karbon-nanoröhrchen enthalten, herstellungsverfahren dafür und verwendung davon
MXPA04009380A (es) Sistema y metodo para la construccion de un proceso de administracion de proyectos.
ATE332411T1 (de) Enzymatische pressfilzbehandlung
WO2005069893A3 (en) Catalyst and method for its manufacture
WO2003018600A3 (en) Antisense modulation of microsomal triglyceride transfer protein expression
NL1015129A1 (nl) Zeoliet IM-5 met fosfor, katalytische samenstelling, de bereiding en toepassing daarvan bij het katalytisch kraken.
WO2005014607A3 (en) Antisense modulation of stearoyl-coa desaturase expression
EP1752534A4 (de) Hochgeschwindigkeits-pcr unter verwendung von hochgeschwindigkeits-dna-polymerase
WO2003088921A3 (en) Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression
WO2003072743A3 (en) Method for the recombination of genetic elements
WO2005052124A3 (en) Modified dna cleaving enzymes and methods of use
WO2003012031A3 (en) Antisense modulation of stearoyl-coa desaturase expression

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties